C4 Therapeutics, Inc. (CCCC) fundamentals chart
CCCCNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 9/302% below fair value
$2.48−0.05 (-2.17%)
Close on Nov 18, 2026Market cap $304.49MP/E –Yield –
Fundamental chart
Pick a measure to chart its full history
$35.95MFY2025, -5.9% a year since FY2021
See a number that looks wrong?